Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

The outbreak of SARS-CoV-2 developed into a global pandemic affecting millions of people worldwide. Despite one year of intensive research, the current treatment options for SARS-CoV-2 infected people are still limited. Clearly, novel antiviral compounds for the treatment of SARS-CoV-2 infected pati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Viruses
Main Authors: van de Sand, Lukas, Bormann, Maren, Alt, Mira, Schipper, Leonie, Heilingloh, Christiane Silke, Steinmann, Eike, Todt, Daniel, Dittmer, Ulf, Elsner, Carina, Witzke, Oliver, Krawczyk, Adalbert
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8066091/
https://ncbi.nlm.nih.gov/pubmed/33918301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13040609
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki